Sort
23,748 grants matching “melanoma”
CLINICAL TRIALS USING TCR TRANSDUCED T CELL FOR ADOPTIVE IMMUNOTHERAPY
$737,794Michael I Nishimura · Loyola University Chicago · P01 · FY2014 · CA
Senior Leaders
$737,786Judith Cheryl Gasson · University Of California Los Angeles · P30 · FY2009 · CA
3D Bioprinted skin models for drug screening
$737,751Marc Ferrer-Alegre · National Center For Advancing Translational Sciences · ZIA · FY2021 · TR
Development of Physiologic Tissue Models to Assess Tumor Explant Response to Immune Checkpoint Blockade
$737,605Roger D. Kamm · Massachusetts Institute Of Technology · U01 · FY2018 · CA
Early Clinical Testing for Melanin Targeting Radio-therapeutic agent in melanoma
$737,540John W Babich · Molecular Insight Pharmaceuticals, Inc. · R44 · FY2011 · CA
Regulation of Lymphocyte Proliferation and Replicative Capacity
$737,535Richard J. Hodes · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
Processed Antigen Characterization by Mass Spectrometry
$737,483Donald F Hunt · University Of Virginia · R01 · FY2009 · AI
Multiscale Modeling to Optimize Inhibition of Oncogenic ERK Pathway Signaling
$737,149Mark A. Lemmon · Yale University · R01 · FY2020 · CA
GCDH Addiction in Melanoma
$736,400Ze'ev A Ronai · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2022 · CA
Tissue Array Research Program
$736,349Stephen Hewitt · Division Of Basic Sciences - Nci · ZIC · FY2013 · CA
A Multi-Institute Survivorship Study of Patients Living with Advanced Cancer Who Have Had Durable Response to Immune Checkpoint Inhibitors
$735,428Song Yao · Roswell Park Cancer Institute Corp · R01 · FY2024 · CA
Personalized Genomic Testing for Melanoma: Maximizing Personal Utility and Reach
$735,067Jennifer L Hay · Sloan-Kettering Inst Can Research · R01 · FY2014 · CA
CLINICAL TRIALS USING TCR TRANSDUCED T CELL FOR ADOPTIVE IMMUNOTHERAPY
$735,043Michael I Nishimura · Loyola University Chicago · P01 · FY2013 · CA
Understanding and Overcoming Resistance to Cancer Immunotherapy Due to Defective Antigen Presentation
$734,862Katerina Abigail Politi · Yale University · R01 · FY2019 · CA
Development of Virtual Tumor
$734,822Thomas S Deisboeck · Massachusetts General Hospital · U56 · FY2006 · CA
Genetic Epidemiology
$734,639Alisa Goldstein · Division Of Cancer Epidemiology And Genetics · ZIA · FY2019 · CA
Mechanisms of racial disparity in breast cancer-related lymphedema
$734,550Babak J Mehrara · Sloan-Kettering Inst Can Research · R01 · FY2025 · CA
Mechanisms of racial disparity in breast cancer-related lymphedema
$734,550Babak J Mehrara · Sloan-Kettering Inst Can Research · R01 · FY2023 · CA
Molecular Diagnostics Core Laboratory
$734,451Mark Raffeld · Division Of Basic Sciences - Nci · ZIC · FY2014 · CA
The COVID-19 and Cancer Consortium (CCC19) Registry
$732,687Jeremy Lyle Warner · Rhode Island Hospital · U01 · FY2024 · CA
LKB1 tumor suppressor and human cancer
$732,590Diego H Castrillon · Ut Southwestern Medical Center · U01 · FY2013 · CA
Biomechanics Of Cochlear Fine Tuning
$732,420Richard S. Chadwick · National Institute On Deafness And Other Communication Disorders · ZIA · FY2015 · DC
Illinois Oncology Research Association Community Clinical Oncology Program
$732,293Nguyet A. Le-Lindqwister · Oncology-Hematology Assoc-Central Ill · U10 · FY2011 · CA
In-Situ Autovaccination against Solid Cancers with Intratumoral Hiltonol (Poly-ICLC): A phase II Adaptive Multicenter Clinical Study
$732,170Andres Mario Salazar · Oncovir, Inc. · R44 · FY2017 · CA
In-Situ Autovaccination against Solid Cancers with Intratumoral Hiltonol (Poly-ICLC): A phase II Adaptive Multicenter Clinical Study
$732,170Andres Mario Salazar · Oncovir, Inc. · R44 · FY2016 · CA